According to The Guardian, surgeons transplanted a gene-edited pig kidney into Tim Andrews, 66, who had end-stage kidney disease and minimal odds of receiving a human organ in time. The xenotransplant functioned for nine months, keeping him off dialysis until he received a deceased donor kidney.
Over 90,000 Americans need a kidney transplant. Fewer than 20,000 get one yearly. The waiting list is where the crisis lives. Most patients face a choice between years on dialysis and never making it to transplant. Nine months of function proves the concept works at scale.
For years, xenotransplantation lived in the gap between miracle headline and medical moonshot. This result moves it into hospital logistics. If surgeons can reliably buy patients months instead of days, the conversation shifts from "Is this possible?" to "Who qualifies, under what rules, and how fast can health systems scale it?" Andrews's nine-month bridge answers the first question. The second one is just beginning.
Filed to the World desk · Sep 3